<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03982784</url>
  </required_header>
  <id_info>
    <org_study_id>cxl2</org_study_id>
    <nct_id>NCT03982784</nct_id>
  </id_info>
  <brief_title>TQLB for Postoperative Pain After Laparoscopic Partial Nephrectomy</brief_title>
  <official_title>Transmuscular Quadratus Lumborum Block for Postoperative Pain After Laparoscopic Partial Nephrectomy: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cui Xulei</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, randomized study,control study aims to compare the analgesic effect,opioids
      consumption,quality of recovery,length of hospital stay，et al. between single-injection
      QLB(quadratus lumborum block)+ intravenous patient-controlled analgesia (IPCA) and
      intravenous patient-controlled analgesia (IPCA) alone in patients undergoing laparoscopic
      partial nephrectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 10, 2019</start_date>
  <completion_date type="Actual">November 10, 2019</completion_date>
  <primary_completion_date type="Actual">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cumulative morphine consumption 8 hours after surgery</measure>
    <time_frame>at the 8 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>cumulative morphine consumption at other time points after surgery</measure>
    <time_frame>at 0, 2, 4, 12, 24 and 48 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The pain scores(at rest or on activity) determined by the numeric rating scale (NRS, 0-10)</measure>
    <time_frame>at 0, 2, 4, 8,12, 24, 48 and 72 hours after surgery</time_frame>
    <description>NRS is an internationally recognized pain scale with 11 points ranging from 0 to 10 points, with 0 defined as no pain and 10 defined as the worst pain imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>episodes of nausea and vomiting</measure>
    <time_frame>within 24 hours after the surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ambulation time</measure>
    <time_frame>within the 5 days after surgery</time_frame>
    <description>time from the end of the surgery to the first time to out-of-bed activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time of recovery of bowl movement</measure>
    <time_frame>within the 5 days after surgery</time_frame>
    <description>time from the end of the surgery to the first time of bowl movement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction with anesthesia</measure>
    <time_frame>at 48 hours after surgery</time_frame>
    <description>Patient satisfaction with anesthesia was assessed using a 5-point scale (5: very satisfied; 4: satisfied; 3: neither satisfied nor dissatisfied; 2: dissatisfied; 1: very dissatisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of recovery evaluated by the self-assessment 15-item quality of recovery (QoR) scale</measure>
    <time_frame>at 72 hours and 120 hours after the sugery</time_frame>
    <description>QoR is a 15-item questionnaire which will score on a scale of 0-10 pertaining to patient's comfort, support system, pain, well-being, and ability to carry out daily activities, where 0 indicates none of the time and 10 indicates all of the time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative length of hospital stay</measure>
    <time_frame>within 2 weeks after the surgery</time_frame>
    <description>time to patient's discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Laparoscopic Renal Surgery</condition>
  <condition>Pain Management</condition>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>single-injection TQLB(transmuscular quadratus lumborum block)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single-injection of TQLB is given preoperatively + postoperative IPCA(intravenous patient controlled analgesia)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>postoperative IPCA is given alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>single-injection TQLB(transmuscular quadratus lumborum block)</intervention_name>
    <description>Inject 0.6ml/kg local anesthetics in between quadratus lumborum and psoas major under ultrasound guidance</description>
    <arm_group_label>single-injection TQLB(transmuscular quadratus lumborum block)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine given as IPCA(intravenous patient controlled analgesia)</intervention_name>
    <description>PCIA was initiated using a pump set to deliver boluses of 1.5-2 mg of morphine with a 5-minute lockout interval and no background infusion. The maximal permitted dosage of morphine was set at 8 mg/h.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>single-injection TQLB(transmuscular quadratus lumborum block)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        inclusion Criteria:

          -  Age 18-70 yrs

          -  American Society of Anesthesiologists physical statusⅠ-Ⅲ

          -  Undergo laparoscopic partial nephrectomy

          -  Informed consent

        Exclusion Criteria:

          -  A known allergy to the drugs being used

          -  Coagulopathy, on anticoagulants

          -  Analgesics intake, history of substance abuse

          -  Participating in the investigation of another experimental agent

          -  Inability to properly describe postoperative pain to investigators (eg, language
             barrier, neuropsychiatric disorder)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cui Xulei</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>June 4, 2019</study_first_submitted>
  <study_first_submitted_qc>June 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2019</study_first_posted>
  <last_update_submitted>November 10, 2019</last_update_submitted>
  <last_update_submitted_qc>November 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Cui Xulei</investigator_full_name>
    <investigator_title>attending physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

